Susquehanna Fundamental Investments’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.56M Sell
111,545
-65,621
-37% -$917K 0.04% 382
2025
Q1
$2.39M Buy
+177,166
New +$2.39M 0.03% 480
2023
Q2
Sell
-22,777
Closed -$579K 885
2023
Q1
$579K Hold
22,777
0.01% 644
2022
Q4
$665K Buy
22,777
+2,540
+13% +$74.2K 0.01% 773
2022
Q3
$415K Buy
+20,237
New +$415K 0.01% 1070